Summit Global Investments Organogenesis Holdings Inc. Transaction History

Summit Global Investments

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$6.47 - $9.57 $952,384 - $1.41 Million	-147,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $828,938 - $1.24 Million	91,900 Added 166.18%	147,200 $1.36 Million
Q3 2021 Nov 08, 2021	SELL	$13.71 - $17.18 $90,486 - $113,388	-6,600 Reduced 10.66%	55,300 $787,000
Q2 2021 Jan 28, 2022	BUY	$14.92 - $23.23 $923,548 - $1.44 Million	61,900 New	61,900 $1.03 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.